Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:26 PM ET 8-K
Other 8-K Filing Apollo Commercial Real Estate Finance, Inc. ARI

Apollo Commercial Real Estate Finance Other 8-K Filing

Stockholders approved the complete liquidation and dissolution of Apollo Commercial Real Estate Finance, Inc. at a special meeting. In connection with the plan, the company entered into a termination agreement with its manager, ACREFI Management, LLC, to end their management agreement without a termination fee upon the effective date of dissolution.

Counterparty
ACREFI Management, LLC
5:26 PM ET 8-K
Leadership Change Celularity Inc CELU

Celularity Leadership Change

Celularity Inc. appointed Naveen Jain, founder and CEO of Viome Life Sciences, to its Board of Directors. Mr. Jain was designated for the role by investors from a recent September 2026 financing, and his appointment coincides with the resignation of director Diane Parks.

Counterparty
Naveen Jain
5:26 PM ET 8-K
Licensing Deal Cboe Global Markets, Inc. CBOE

Cboe Global Markets Licensing Deal with S&P Opco, LLC

Cboe Global Markets has signed a 25-year extension of its exclusive licensing agreement with S&P Dow Jones Indices, securing the rights to list and trade S&P 500 index options through 2051. The agreement updates royalty fee terms starting in 2027 on a per-contract basis and includes cross-licenses for Volatility Indices (VIX) and other intellectual property. Management expects the updated fee structure to have a de minimis impact on 2027 net revenue growth relative to organic volume increases.

Counterparty
S&P Opco, LLC
Term
through Dec 2051
5:25 PM ET 8-K
Dividend Aterian, Inc. ATER

Aterian Dividend

Aterian, Inc. announced a cash distribution of approximately $0.9936 per Contingent Value Right (CVR) to be paid on or about October 2, 2026. The payment follows the completion of an asset sale to Trademark Global, LLC and a secondary securities purchase agreement closing, which triggered 'Proceeds Events' under the CVR Agreement. Additionally, the company reported a change in control as David E. Lazar sold his preferred stock interests for $12 million, resulting in the appointment of William H. Crampton to the board.

Counterparty
Broadridge Corporate Issuer Solutions, LLC
5:25 PM ET 8-K
M&A Deal Marketaxess Holdings Inc MKTX

Marketaxess Holdings M&A Deal with Intercontinental Exchange, Inc.

MarketAxess and Intercontinental Exchange (ICE) have refiled their HSR Act premerger notifications to provide the DOJ with additional time for review, extending the waiting period to October 29, 2026. The companies continue to expect the merger to close in the first half of 2027, subject to stockholder approval and regulatory clearance. A special meeting for MarketAxess stockholders to vote on the merger is scheduled for October 29, 2026.

Counterparty
Intercontinental Exchange, Inc. (ICE)
5:25 PM ET 8-K
Loan & Debt Delek US Holdings, Inc. DK

Delek US Holdings $460M Debt Financing with U.S. Bank Trust Company, National Association

Delek US Holdings completed a private offering of $460 million in 0.00% convertible senior notes due 2031, which includes the full exercise of the initial purchasers' overallotment option. The proceeds will be used to fund capped call transactions to mitigate dilution and for the partial repayment of outstanding debt under the company's Term Loan Credit Facility.

Value
$460M
Counterparty
U.S. Bank Trust Company, National Association
Term
through Nov 2031
5:22 PM ET 8-K
Other 8-K Filing Spark I Acquisition Corp SPKLF

Spark I Acquisition Other 8-K Filing

Spark I Acquisition Corp (SPKL) announced a deadline extension for its initial business combination from September 2026 to March 2027. To support this, the Sponsor issued a $0.4 million promissory note to fund monthly trust account contributions and will make a one-time additional deposit of $0.10 per share to incentivize shareholders not to redeem their shares.

Counterparty
SLG SPAC Fund LLC
Term
through March 29, 2027
5:22 PM ET 8-K
Capital Raise Kennedy Lewis Capital Co

Kennedy Lewis Capital Capital Raise of $678M

Kennedy Lewis Capital Company reported that it has raised approximately $677.6 million in total consideration to date through its ongoing $2.0 billion continuous public offering and private placement of common shares. As of August 31, 2026, the company's aggregate net asset value was $734.5 million with a portfolio fair value of $1.27 billion.

Value
$678M
5:21 PM ET 8-K
Shareholder Meeting Techprecision Corp TPCS

Techprecision Shareholder Meeting

TechPrecision Corporation held its 2026 Annual Meeting of Stockholders on September 29, 2026, where shareholders elected five directors and ratified CBIZ CPAs P.C. as the independent auditor. Stockholders also approved an advisory vote on executive compensation and an amendment to the 2016 Equity Incentive Plan to increase the authorized share pool by 750,000 shares.

5:20 PM ET 8-K
Other 8-K Filing GEN Restaurant Group, Inc. GENK

GEN Restaurant Group Other 8-K Filing

GEN Restaurant Group entered into a Common Stock Purchase Agreement with Roth Principal Investments, establishing a committed equity facility. The company has the right, but not the obligation, to sell up to $25 million of Class A common stock to Roth from time to time over a 36-month period following the effectiveness of a registration statement.

Counterparty
Roth Principal Investments, LLC
Term
36 months
5:20 PM ET 8-K
Clinical Trial Data Tectonic Therapeutic, Inc. TECX

Tectonic Therapeutic Clinical Trial Data

Tectonic Therapeutic announced favorable topline results from its Phase 1a clinical trial of TX2100, demonstrating that single ascending doses were generally safe and well-tolerated in healthy volunteers. The company also received FDA Fast Track designation and IND clearance to proceed with Phase 1b and Phase 2 trials in patients with Hereditary Hemorrhagic Telangiectasia (HHT).

5:17 PM ET 8-K
Dividend T. Rowe Price OHA Select Private Credit Fund OCREDIT

T. Rowe Price OHA Select Private Credit Fund Dividend

T. Rowe Price OHA Select Private Credit Fund declared regular monthly distributions for September 2026 across its Class I, S, and D common shares, payable on October 30, 2026. The fund also reported a net asset value (NAV) per share of $26.07 as of August 31, 2026, with an aggregate NAV of approximately $1.62 billion.

5:16 PM ET 8-K
Leadership Change BioAtla, Inc. BCAB

BioAtla Leadership Change

Dr. Eric Sievers resigned as Chief Medical Officer of BioAtla, Inc. effective September 25, 2026, and will transition to a consulting role through June 2027. Additionally, the company reinstated retention bonus programs for CEO Jay M. Short and CFO Christian Vasquez, contingent on achieving financial and capital raising milestones by year-end 2026.

5:16 PM ET 8-K
Investor Presentation MongoDB, Inc. MDB

MongoDB Investor Presentation

MongoDB hosted an Investor Day on September 29, 2026, to discuss long-term growth strategies and financial targets. Alongside the event, the company announced that its Board of Directors authorized an additional $1.0 billion for its share repurchase program, bringing the total authorized amount to $2.0 billion.

5:15 PM ET 8-K
Other 8-K Filing Aspire-Lakewood Holdings, Inc. ASBP

Aspire-Lakewood Holdings Other 8-K Filing

Aspire-Lakewood Holdings, Inc. dismissed Turner Stone & Company, LLP as its independent registered public accounting firm and appointed CBIZ CPAs P.C. as its new auditor. The company noted that its previous audit report included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern and previously disclosed material weaknesses in internal controls.

Counterparty
CBIZ CPAs P.C.
5:15 PM ET 8-K
Business Update Sable Offshore Corp. SOC

Sable Offshore Business Update

Sable Offshore Corp. provided an operational update regarding the pending restart of Platform Hondo, noting that reconstruction is complete and final regulatory approval from the Marine Minerals Administration is expected in October 2026. The company is also upgrading its Las Flores Canyon facility to increase processing capacity and reported preliminary September oil sales of approximately 34,000 gross barrels per day.

5:12 PM ET 8-K
Leadership Change Lgam Private Credit LLC

Lgam Private Credit Leadership Change

Kevin Shannon resigned from his position as a Director of LGAM Private Credit LLC, effective September 26, 2026. The company stated that his departure was not the result of any disagreement with the registrant.

5:11 PM ET 8-K
Leadership Change Northern Trust Corp NTRS

Northern Trust Leadership Change

David W. Fox, Jr., Chief Financial Officer of Northern Trust Corporation, has announced his intention to retire effective on or around March 31, 2027. The company has initiated a comprehensive internal and external search for a successor, and Fox will remain in his role through the end of Q1 2027 to ensure an orderly transition.

5:07 PM ET 8-K
Shareholder Meeting John Wiley & Sons, Inc. WLY

John Wiley & Sons Shareholder Meeting

John Wiley & Sons, Inc. held its 2026 Annual Meeting of Shareholders on September 24, 2026. Shareholders elected nine directors, ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2027, and approved the advisory resolution on executive compensation.

5:07 PM ET 8-K
Shareholder Meeting Fedex Corp FDX

Fedex Shareholder Meeting

FedEx held its 2026 annual meeting of stockholders where eleven directors were elected and executive compensation was approved on an advisory basis. Stockholders also ratified the appointment of Ernst & Young LLP as the independent auditor for the transition period ending December 31, 2026, and rejected a stockholder proposal for an independent board chair. Additionally, the board approved a $20,000 increase to the annual equity grant for non-management directors.

5:02 PM ET 8-K
Stock Buyback Talen Energy Corp TLN

Talen Energy Announces $1.5B Stock Buyback

Talen Energy announced a $1.5 billion accelerated share repurchase (ASR) and upsized its total share repurchase program to $3.0 billion through 2028. Simultaneously, the company announced a leadership succession plan where President Terry Nutt will succeed Mac McFarland as CEO effective January 1, 2027.

Value
$1.5B
Term
through 2028
5:01 PM ET 8-K
Executive Compensation NextBoat Inc. NXB

NextBoat Executive Compensation

NextBoat Inc. appointed Ross Tannenbaum as Chief Executive Officer, succeeding Brian John who will remain on the Board. In connection with the appointment, the company entered into a four-year employment agreement and granted Mr. Tannenbaum stock options for 2.5 million shares, including performance-based tranches tied to Adjusted EBITDA and stock price milestones.

Counterparty
Ross Tannenbaum
Term
4 years
5:01 PM ET 8-K
Shareholder Meeting Bone Biologics Corp BBLG

Bone Biologics Shareholder Meeting

Bone Biologics Corp held its Annual Meeting of stockholders on September 28, 2026, where shareholders elected four directors and ratified Weinberg & Company, P.A. as the independent auditor. Stockholders also approved a potential reverse stock split at a ratio between 1-for-2 and 1-for-10 and authorized the potential issuance of shares underlying warrants in excess of 20% of outstanding stock to comply with Nasdaq rules.

5:01 PM ET 8-K
M&A Deal Sino Green Land Corp. SGLA

Sino Green Land M&A Deal with Xing Da Plastics Sdn. Bhd. and Invent Fortune Sdn. Bhd.

Sino Green Land Corporation completed the acquisition of a 60% stake in Xing Da Plastics Sdn. Bhd. and 100% of Invent Fortune Sdn. Bhd. As consideration, the company issued approximately 41.3 million shares of its common stock to the sellers of both entities. These acquisitions represent a significant expansion of the company's asset base in the plastics and industrial sectors.

Counterparty
Xing Da Plastics Sdn. Bhd. and Invent Fortune Sdn. Bhd.
5:00 PM ET 8-K
Licensing Deal Heron Therapeutics, Inc. HRTX

Heron Therapeutics Licensing Deal with Long Grove Pharmaceuticals, LLC

Heron Therapeutics entered into a multi-product Development and License Agreement with Long Grove Pharmaceuticals and Capstone Development Services. The agreement grants Heron an exclusive license to import, distribute, and market certain products in the U.S. in exchange for regulatory milestones, sales-based milestones, and royalty payments.

Counterparty
Long Grove Pharmaceuticals, LLC
Term
10 years
5:00 PM ET 8-K
Leadership Change North Haven Private Income Fund LLC

North Haven Private Income Fund Leadership Change

Kevin Shannon notified North Haven Private Income Fund LLC of his resignation from the Board of Directors, effective September 26, 2026. The company stated that the departure was not due to any disagreement with the company's operations, policies, or practices.

Counterparty
Kevin Shannon
5:00 PM ET 8-K
Leadership Change Crane Co CR

Crane Leadership Change

James L. L. Tullis, the Lead Independent Director of Crane Co, has tendered his resignation from the Board of Directors effective at the conclusion of the 2027 Annual Meeting of Stockholders. The resignation is in accordance with the company's retirement policy for directors and is not due to any disagreement with the company. The Board will begin a process to identify a successor for the Lead Independent Director role.

4:58 PM ET 8-K
Leadership Change T Series BDC LLC

T Series BDC Leadership Change

Kevin Shannon resigned from his position as a Director of T Series BDC LLC, effective September 26, 2026. The company stated that the resignation was not the result of any disagreement with the firm.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.